about
Risk associated with bee venom therapy: a systematic review and meta-analysisHymenoptera Allergy and Mast Cell Activation Syndromes.Basophilic histamine content and release during venom immunotherapy: insights by flow cytometry.Down-regulation of FcεRI-mediated CD63 basophil response during short-term VIT determined venom-nonspecific desensitization.Research needs in allergy: an EAACI position paper, in collaboration with EFA.One century of allergen-specific immunotherapy for respiratory allergy.Honeybee venom immunotherapy: certainties and pitfalls.Allergen immunotherapy for insect venom allergy: a systematic review and meta-analysis.Allergen-specific immunotherapy of Hymenoptera venom allergy - also a matter of diagnosis.Component-resolved evaluation of the content of major allergens in therapeutic extracts for specific immunotherapy of honeybee venom allergy.Honeybee venom immunotherapy: a comparative study using purified and nonpurified aqueous extracts in patients with normal Basal serum tryptase concentrations.Prophylactic immunization of mice with phospholipase A2-loaded gas-filled microbubbles is protective against Th2-mediated honeybee venom allergy.Hymenoptera Venom Immunotherapy: Tolerance and Efficacy of an Ultrarush Protocol versus a Rush and a Slow Conventional ProtocolSelf-medication of anaphylactic reactions due to Hymenoptera stings-an EAACI Task Force Consensus Statement.Efficacy of a therapeutic treatment using gas-filled microbubble-associated phospholipase A2 in a mouse model of honeybee venom allergy.Venom immunotherapy: pitfalls and open questions.Short-term venom immunotherapy induces desensitization of FcεRI-mediated basophil response.Treatment with a combination of omalizumab and specific immunotherapy for severe anaphylaxis after a wasp sting.
P2860
Q28547393-2A0B63EE-DAB6-409C-8C19-6925BE912565Q33166619-0E862F7D-55B2-4CAF-904E-787F7BFC2AB6Q34602183-8CE2332D-743B-4B28-A450-C25FDD3F3EB5Q35148103-1185E8D9-699F-4B1B-BDD4-06BED39DA1AFQ36517533-2E778708-A10F-48A7-89CF-EDABD4FB2FEFQ37873483-6F024D06-8E6A-4250-A440-450C6B142F1EQ38063584-B96E4F5D-CCEF-4E9E-8F76-B5476D10E77FQ39000691-FE6BD281-3C1A-41D6-8803-EDC90329CE08Q39366204-8DF677EB-5F24-4702-986C-3307E30989C0Q40217023-3FC84D35-4BCB-4006-BF34-72A88677F36FQ40582052-36770D22-62D2-4BC4-9423-88728153746CQ41031692-08323533-5A7E-401E-BFA8-A6E4E91F0165Q42121666-13B7AB88-428B-4826-8508-E4A2D949010EQ51533907-EAA50E75-11A9-4937-B0CC-41572B315E3CQ51533953-73463657-5CB8-407E-9F99-F7699F633C27Q52730189-E7201A5F-6604-4A41-A7BF-721CEC9F39A7Q52744921-F636EBF7-FBED-43C9-AE9A-29F401E0C579Q52768891-2B6D9F40-726D-4861-BB95-1543FD464CDD
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hymenoptera venom immunotherapy.
@en
Hymenoptera venom immunotherapy.
@nl
type
label
Hymenoptera venom immunotherapy.
@en
Hymenoptera venom immunotherapy.
@nl
prefLabel
Hymenoptera venom immunotherapy.
@en
Hymenoptera venom immunotherapy.
@nl
P2860
P921
P356
P1433
P1476
Hymenoptera venom immunotherapy.
@en
P2093
Beatrice M Bilò
Floriano Bonifazi
P2860
P304
P356
10.2217/IMT.10.88
P577
2011-02-01T00:00:00Z